BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28012230)

  • 1. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
    Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
    Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.
    Wang J; Liu G; Li Q; Wang F; Xie F; Zhai R; Guo Y; Chen T; Zhang N; Ni W; Yuan H; Tai G
    Oncotarget; 2015 Aug; 6(22):19264-78. PubMed ID: 26057631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Mucin1 knockdown on the phenotypic characteristics of the human hepatocellular carcinoma cell line SMMC-7721.
    Li Q; Wang F; Liu G; Yuan H; Chen T; Wang J; Xie F; Zhai R; Wang F; Guo Y; Ni W; Tai G
    Oncol Rep; 2014 Jun; 31(6):2811-9. PubMed ID: 24737121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
    Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
    J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Chan KK; Leung CO; Wong CC; Ho DW; Chok KS; Lai CL; Ng IO; Lo RC
    Cancer Lett; 2017 Sep; 403():330-338. PubMed ID: 28688970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
    Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J; Luo Z; Yao T; Li W; Pu J
    J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
    Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
    Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
    Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
    Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X; Chen M; Liu Z
    Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways.
    Yuan H; Wang J; Wang F; Zhang N; Li Q; Xie F; Chen T; Zhai R; Wang F; Guo Y; Ni W; Tai G
    Mol Med Rep; 2015 Nov; 12(5):6782-8. PubMed ID: 26398332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.
    Ou DL; Shen YC; Yu SL; Chen KF; Yeh PY; Fan HH; Feng WC; Wang CT; Lin LI; Hsu C; Cheng AL
    Cancer Res; 2010 Nov; 70(22):9309-18. PubMed ID: 21062976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma.
    Sui C; Zhuang C; Sun D; Yang L; Zhang L; Song L
    Oncotarget; 2017 Jul; 8(28):45837-45847. PubMed ID: 28507277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
    Okada M; Shibuya K; Sato A; Seino S; Watanabe E; Suzuki S; Seino M; Kitanaka C
    Oncol Rep; 2013 Oct; 30(4):1957-64. PubMed ID: 23912840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.